安道麦有限公司 提供了有关其 2019 年第四季度和全年业绩的估计。
销售量
安道麦预计第四季度销售额将创历史新高，以美元计算增长超过 7%，以人民币计算增长 9%，推动全年销售额达到 $40 亿，再创公司历史新高，克服了这一年中出现的重大逆风。
In the fourth quarter, the expected revenue growth was driven by a combination of robust business growth alongside certain price increases, which more than offset the impact of missing sales of key products manufactured at the Jingzhou old site stemming from the site disruption there during the year, as well as currency headwinds. The company is expecting to report strong growth in Europe, where it saw an early start to the 2020 season, as well as in North America and Asia-Pacific. Noteworthy results are also seen in Brazil, led by a strong performance from CRONNOS, and across Latin America, where the company’s differentiated product offering continues to grow with the inclusion of ARMERO, ADAMA’s first self-produced Prothioconazole-based mixture recently launched in Paraguay, opening up a $1 billion market.